Pacific Shuanglin Bio-pharmacy Co., Ltd. (SHE:000403)

China · Delayed Price · Currency is CNY

14.03

+0.14 (1.01%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Jan '21 Jan 1, 2021	Jan '20 Jan 1, 2020	Jan '19 Jan 1, 2019	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Pharmaceutical Industry	2.65B	2.33B	2.40B	1.97B	1.04B
Pharmaceutical Industry Growth	14.11%	-2.93%	21.82%	88.63%	13.85%
Unallocated Others	1.05M	3.27M	9.59M	5.27M	7.44M
Unallocated Others Growth	-67.93%	-65.97%	82.15%	-29.20%	-
Total	2.65B	2.33B	2.41B	1.97B	1.05B
Total Growth	14.00%	-3.18%	21.98%	87.80%	14.67%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Jan '21 Jan 1, 2021	Jan '20 Jan 1, 2020	Jan '19 Jan 1, 2019	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
China	2.65B	2.29B	2.29B	1.95B	1.05B
China Growth	15.70%	-0.04%	17.31%	86.10%	14.67%
Foreign	3.60M	37.43M	113.06M	17.82M	-
Foreign Growth	-90.38%	-66.90%	534.38%	-	-
Total	2.65B	2.33B	2.41B	1.97B	1.05B
Total Growth	14.00%	-3.18%	21.98%	87.80%	14.67%

Source: S&P Global Market Intelligence.